Portable Device Being Developed to Detect Zika at POC
By LabMedica International staff writers Posted on 10 Mar 2017 |
Image: The Zika virus is transmitted to humans through the bite of an infected Aedes mosquito, such as A. aegypti (Image courtesy of Florida Atlantic University).
A handheld diagnostic device may enable detection of Zika virus accurately, rapidly, and inexpensively in many settings, even at airports as it requires only a saliva sample.
Researchers from Florida Atlantic University have been developing a diagnostic tool to reduce the impact of the Zika outbreak until a vaccine is developed. “Most of the Zika cases in the United States and especially in Florida are travel related,” said Waseem Asghar, PhD, lead investigator and assistant professor at FAU, “We are working to develop a tool that can be used without expensive laboratory equipment and skilled technicians […]. For about USD 2 and within 15 minutes, we hope to accurately determine whether or not an individual has an active infection.”
Currently, patients are often diagnosed by testing blood samples for antibodies against Zika virus, however, due to cross-reaction problems the antibody test does not discriminate accurately between the Zika virus and other flaviviruses such as Dengue, West Nile virus, and Chikungunya. The more accurate method of PCR detection of viral DNA is costly, requires skilled laboratory personnel, and can take hours to yield results.
This new device is based on technology that Prof. Asghar and colleagues initially developed to detect HIV. It uses inexpensive paper- or plastic-based materials, a cassette-sized container holding up to 12 samples at a time, and a receptacle about the size of a tablet. These materials are easy to make and use, and can easily and safely be disposed of by burning, providing an appealing strategy developing, low- and middle-income countries where there is limited laboratory infrastructure.
They are currently adapting their device to diagnose the Zika virus.
Researchers from Florida Atlantic University have been developing a diagnostic tool to reduce the impact of the Zika outbreak until a vaccine is developed. “Most of the Zika cases in the United States and especially in Florida are travel related,” said Waseem Asghar, PhD, lead investigator and assistant professor at FAU, “We are working to develop a tool that can be used without expensive laboratory equipment and skilled technicians […]. For about USD 2 and within 15 minutes, we hope to accurately determine whether or not an individual has an active infection.”
Currently, patients are often diagnosed by testing blood samples for antibodies against Zika virus, however, due to cross-reaction problems the antibody test does not discriminate accurately between the Zika virus and other flaviviruses such as Dengue, West Nile virus, and Chikungunya. The more accurate method of PCR detection of viral DNA is costly, requires skilled laboratory personnel, and can take hours to yield results.
This new device is based on technology that Prof. Asghar and colleagues initially developed to detect HIV. It uses inexpensive paper- or plastic-based materials, a cassette-sized container holding up to 12 samples at a time, and a receptacle about the size of a tablet. These materials are easy to make and use, and can easily and safely be disposed of by burning, providing an appealing strategy developing, low- and middle-income countries where there is limited laboratory infrastructure.
They are currently adapting their device to diagnose the Zika virus.
Latest Microbiology News
- New CE-Marked Hepatitis Assays to Help Diagnose Infections Earlier
- 1 Hour, Direct-From-Blood Multiplex PCR Test Identifies 95% of Sepsis-Causing Pathogens
- Mouth Bacteria Test Could Predict Colon Cancer Progression
- Unique Metabolic Signature Could Enable Sepsis Diagnosis within One Hour of Blood Collection
- Groundbreaking Diagnostic Platform Provides AST Results With Unprecedented Speed
- Simple Blood Test Combined With Personalized Risk Model Improves Sepsis Diagnosis
- Blood Analysis Predicts Sepsis and Organ Failure in Children
- TB Blood Test Could Detect Millions of Silent Spreaders
- New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours
- New Tuberculosis Test to Expand Testing Access in Low- and Middle-Income Countries
- Rapid Test Diagnoses Tropical Disease within Hours for Faster Antibiotics Treatment
- Rapid Molecular Testing Enables Faster, More Targeted Antibiotic Treatment for Pneumonia
- Rapid AST Platform Provides Targeted Therapeutic Results Days Faster Than Current Standard of Care
- New Analysis Method Detects Pathogens in Blood Faster and More Accurately by Melting DNA
- Rapid Sepsis Test Delivers Two Days Faster Results
- Portable Rapid PCR Diagnostic to Detect Gonorrhea and Antibiotic Susceptibility